Synovial sarcoma
Synovial sarcoma | |
---|---|
Other names | Malignant synovioma |
Micrograph of a monophasic synovial sarcoma. The histologic appearance is non-specific and overlaps with MPNST and fibrosarcoma. H&E stain. | |
Specialty | Oncology |
A synovial sarcoma (also known as malignant synovioma[1]) is a rare form of cancer which occurs primarily in the extremities of the arms or legs, often in proximity to joint capsules and tendon sheaths.[2] It is a type of soft-tissue sarcoma.
The name "synovial sarcoma" was coined early in the 20th century, as some researchers thought that the microscopic similarity of some tumors to
Primary synovial sarcomas are most common in the soft tissue near the large joints of the arm and leg but have been documented in most human tissues and organs, including the brain, prostate, and heart.
Synovial sarcoma occurs in about 1–2 per 1,000,000 people a year.[4] They occur most commonly in the third decade of life, with males being affected more often than females (ratio around 1.2:1).[4][2]
Signs and symptoms
Synovial sarcoma usually presents with an otherwise asymptomatic swelling or mass, although general symptoms related to malignancies can be reported such as fatigue.[5]
Diagnosis
The diagnosis of synovial sarcoma is typically made based on histology and is confirmed by the presence of t(X;18) chromosomal translocation.[6]
Histopathology
Two cell types can be seen microscopically in synovial sarcoma. One fibrous type, known as a spindle or sarcomatous cell, is relatively small and uniform, and found in sheets. The other is
Like other
Immunohistochemistry (IHC): SS18-fusion specific antibody and SSX-CT antibody are highly sensitive and specific for synovial sarcoma and when used together may obviate the need for molecular testing in most cases.[9][10] Cytokeratin is typically expressed, at least focally. TLE1, BCL2 and CD99 may be positive but lack specificity.
Molecular biology
Most, and perhaps all, cases of synovial sarcoma are associated with a reciprocal translocation t(x;18)(p11.2;q11.2). There is some debate about whether the molecular observation itself is definitive of synovial sarcoma.[11][12][13]
The diagnosis of synovial sarcoma is typically made based on histology and is confirmed by the presence of t(X;18).[6] This translocation event between the SS18 gene on chromosome 18 and one of 3 SSX genes (SSX1, SSX2 and SSX4) on chromosome X causes the presence of an SS18-SSX fusion gene. The resulting fusion protein brings together the transcriptional activating domain of SS18 and the transcriptional repressor domains of SSX. It also incorporates into the SWI/SNF chromatin remodeling complex, a well known tumor suppressor.[14] SS18-SSX is thought to underlie synovial sarcoma pathogenesis through dysregulation of gene expression.[3]
There is some association between the SS18-SSX1 or SS18-SSX2 fusion type and both tumour morphology and five-year survival.[15]
Treatment
Treatment is usually multimodal, involving surgery, chemotherapy and radiotherapy:[16]
- Surgery, to remove the tumor and a safety margin of healthy tissue. This is the mainstay of synovial sarcoma treatment and is curative in approximately 20–70% of patients, depending on the particular study being quoted.[17]
- Conventional
References
- ^ "Synovioma". Encyclopædia Britannica Online. Retrieved 20 May 2012.
- ^ LCCN 2013010770.
- ^ ISBN 155009128X.
- ^ a b Ferrari and Collini (2012). "Synovial Sarcoma". ESUN. 9 (5).
- ^ 楊照彬 (2010). "青少年骨髓性肉瘤初期以背痛呈現: 病例報告". 台灣復健醫學雜誌 (in Chinese). 38 (4): 269–275.
- ^ PMID 14669292.
- ^ PMID 17090186.
- ISSN 0268-0890.
- S2CID 219949018.
- PMID 32141887.
- ^
Pfeifer, John D.; Hill, D. Ashley; O'Sullivan, Maureen J.; Dehner, Louis P. (4 January 2002). "Diagnostic gold standard for soft tissue tumours: morphology or molecular genetics?". S2CID 6825413.
- ^
O'Sullivan, Maureen J.; Kyriakos, M.; Zhu, X.; Wick, M.R.; Swanson, P.E.; Dehner, Louis P.; Humphrey, P.A.; Pfeifer, John D. (2000). "Malignant peripheral nerve sheath tumors with t(X;18). A pathologic and molecular genetic study". PMID 11144931.
- ^
Coindre, Jean-Michel; Hostein, Isabelle; Benhattar, Jean; Lussan, Cathy; Rivel, Janine; Guillou, Louis (June 2002). "Malignant Peripheral Nerve Sheath Tumors are t(X;18)-Negative Sarcomas. Molecular Analysis of 25 Cases Occurring in Neurofibromatosis Type 1 Patients, Using Two Different RT-PCR-Based Methods of Detection". PMID 12065770.
- PMID 22442726.
- (PDF) from the original on 26 August 2017.
- ^ PMID 25438927.
- PMID 10811674.
- ^ Ren, Xiao-Hua; WU, Xiao-Min; JIN, Cheng; CUI, Yong-An (2009). "Advances in the diagnosis and treatment of synovial sarcoma". Journal of Medical Biomechanics (in Chinese). 15 (4): 541–542. Retrieved 7 May 2016.
External links
- Media related to Synovial sarcoma at Wikimedia Commons
- Sarcoma Help: What is Synovial Sarcoma?
- WebMD: Synovial Sarcoma Overview